Literature DB >> 24814157

Bead-based multiplex sexually transmitted infection profiling.

Markus Schmitt1, Christophe Depuydt2, Michel Stalpaert2, Michael Pawlita3.   

Abstract

OBJECTIVES: Sexually transmitted infections are a significant cause of genital disease, infertility and hospital admissions. The economic impact is high. An accurate diagnosis is often difficult and time consuming. We report the development and validation of a novel bead-based multiplex sexually transmitted infection profiling (STIP) assay that detects 18 sexually transmitted infections using a multiplex PCR followed by Luminex bead-based hybridisation.
METHODS: STIP was validated using urogenital samples pretested by commercially available quantitative PCR, microscopy or by culturing methods.
RESULTS: STIP specifically detects Chlamydia trachomatis, Herpes simplex virus 1 and 2, Treponema pallidum, Trichomonas vaginalis, Neisseria gonorrhoeae, Mycoplasma (M.) genitalium, M. hominis, M. pneumonia, M. spermatophilum, Ureaplasma urealyticum and U. parvum, and quantifies bacterial vaginosis-associated Atopobium vaginae and Gardnerella vaginalis as well as three Candida species and normal genital flora-associated Lactobacillus species. STIP reached an overall concordance of 95-100% with commercially available quantitative PCR tests. Compared to Nugent score, STIP reached a sensitivity of 95% and a specificity of 86% for bacterial vaginosis detection. Candida specimens, pretested by direct culturing, were identified with a sensitivity of 97% and a specificity of 99%.
CONCLUSIONS: STIP is a powerful high-throughput tool in assessing a broad spectrum of urogenital infections.
Copyright © 2014 The British Infection Association. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Bacterial vaginosis; Luminex; PCR; Screening; Sexually transmitted infection (STI); Sexually transmitted infection profiling (STIP)

Mesh:

Substances:

Year:  2014        PMID: 24814157     DOI: 10.1016/j.jinf.2014.04.006

Source DB:  PubMed          Journal:  J Infect        ISSN: 0163-4453            Impact factor:   6.072


  6 in total

Review 1.  Bridging the gap between development of point-of-care nucleic acid testing and patient care for sexually transmitted infections.

Authors:  Kuangwen Hsieh; Johan H Melendez; Charlotte A Gaydos; Tza-Huei Wang
Journal:  Lab Chip       Date:  2022-02-01       Impact factor: 7.517

Review 2.  Chlamydia trachomatis and Genital Mycoplasmas: Pathogens with an Impact on Human Reproductive Health.

Authors:  Sunčanica Ljubin-Sternak; Tomislav Meštrović
Journal:  J Pathog       Date:  2014-12-31

3.  Simultaneous detection of eleven sexually transmitted agents using multiplexed PCR coupled with MALDI-TOF analysis.

Authors:  Leshan Xiu; Chi Zhang; Yamei Li; Feng Wang; Junping Peng
Journal:  Infect Drug Resist       Date:  2019-08-28       Impact factor: 4.003

4.  Feasibility and acceptance of cervicovaginal self-sampling within the German National Cohort (Pretest 2).

Authors:  Stefanie Castell; G Krause; M Schmitt; M Pawlita; Y Deleré; N Obi; D Flesch-Janys; Y Kemmling; A M Kaufmann
Journal:  Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz       Date:  2014-11       Impact factor: 1.513

5.  Association of human papillomavirus and Chlamydia trachomatis with intraepithelial alterations in cervix samples.

Authors:  Denise Wohlmeister; Débora Renz Barreto Vianna; Virgínia Etges Helfer; Fabrícia Gimenes; Marcia Edilaine Lopes Consolaro; Regina Bones Barcellos; Maria Lucia Rossetti; Luciane Noal Calil; Andréia Buffon; Diogo André Pilger
Journal:  Mem Inst Oswaldo Cruz       Date:  2016-02-02       Impact factor: 2.743

6.  Immunoprofiling of Chlamydia trachomatis using whole-proteome microarrays generated by on-chip in situ expression.

Authors:  Katrin Hufnagel; Smiths Lueong; Martina Willhauck-Fleckenstein; Agnes Hotz-Wagenblatt; Beiping Miao; Andrea Bauer; Angelika Michel; Julia Butt; Michael Pawlita; Jörg D Hoheisel; Tim Waterboer
Journal:  Sci Rep       Date:  2018-05-14       Impact factor: 4.379

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.